SCHEMBL3454517

SCHEMBL3454517

Clc1ccc(Oc2ccc3c(Cl)nc4ncccc4c3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 3/20 0.43
SCN9A Q15858 3/20 0.38
RAB9A P51151 1/20 0.38
KDR P35968 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
BCHE P06276 4/20 0.37
ACHE P22303 4/20 0.37
MAPK1 P28482 1/20 0.37
SLC2A1 P11166 1/20 0.37
IDO1 P14902 1/20 0.36
HTT P42858 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6523544 0.89 HCAR2 (0.46) HCAR2SCN9AIDO1MEN1KMT2A
SCHEMBL3453991 0.89 RAB9A (0.41) HCAR2RAB9AALDH1A1BCHEACHE
SCHEMBL6517522 0.86 CYP19A1 (0.44) HCAR2SCN9AKDM4EEGLN1
SCHEMBL3454218 0.86 BCHE (0.41) RAB9AKDM4EALDH1A1BCHEACHE
SCHEMBL3453868 0.84 ABCG2 (0.44) RAB9ABCHEACHEIDO1THRB
SCHEMBL6520629 0.84 HCAR2 (0.45) HCAR2KDM4EALDH1A1BCHEACHE
SCHEMBL6524942 0.84 IDO1 (0.45) HCAR2ALDH1A1ACHEMAPK1IDO1
SCHEMBL6525007 0.81 KDM4E (0.41) HCAR2KDM4EALDH1A1MAPK1
SCHEMBL6527179 0.77 IDO1 (0.45) HCAR2ALDH1A1ACHEMAPK1IDO1
SCHEMBL6527176 0.77 MAT2A (0.42) SCN9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
EP-2254889-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF Merck Patent GmbH (DE) 2010-12-01 EP disclosed
WO-2009108670-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK SERONO S.A. (CH) 2009-09-03 WO disclosed
WO-2009108670-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK SERONO S.A. (CH) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MAP4K2, MAP3K20, MAP4K1 HCAR2 4241/4885SCN9A 2914/4885RAB9A 1390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.